| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.032 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.03 | 0.9 |